DENTSPLY SIRONA (XRAY) Stock Analysis & AI Equity Report

Medical - Instruments & Supplies USD Explore free reports

DENTSPLY SIRONA (XRAY) overview

DENTSPLY SIRONA (XRAY) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 3,680m and operating profit of USD -422m; the year-end share price was 11.43 USD and market capitalisation was USD 2,281m. DENTSPLY SIRONA is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get DENTSPLY SIRONA's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 1,339mFY 2025
Share price11.43 USDFY 2025 year end
RevenueUSD 3,680mFY 2025
Operating profitUSD -422mFY 2025
Net earningsUSD -598mFY 2025
Market capitalisationUSD 2,281mFY 2025 year end

About DENTSPLY SIRONA

DENTSPLY SIRONA develops, manufactures, and sells professional dental products and technologies, as well as healthcare consumables for urological and enterological applications. Its offerings include dental equipment and instruments, imaging systems, treatment centers, CAD/CAM products, implants, clear aligners, and consumables. It also provides cloud-based digital services and software. Customers include dental practitioners and specialists, with products distributed globally.

Generate the DENTSPLY SIRONA report

DENTSPLY SIRONA is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for DENTSPLY SIRONA and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on DENTSPLY SIRONA

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.